bluuebunny/crossref_metadata_2025 huggingface dataset:
Data from Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer
Authors: Yue Taohua , Li Jichang , Zhu Jing , Zuo Shuai , Wang Xin , Liu Yucun , Liu Jia , Liu Xiaoyun , Wang Pengyuan , Chen Shanwen
Published: March 2023

Abstract
Immunotherapy can elicit robust anticancer responses in the clinic. However, a large proportion of patients with colorectal cancer do not benefit from treatment. Although previous studies have shown that hydrogen sulfide (H2S) is involved in colorectal cancer development and immune escape, further insights into the mechanisms and related molecules are needed to identify approaches to reverse the tumor-supportive functions of H2S. Here, we observed significantly increased H2S levels in colorectal cancer tissues. Decreasing H2S levels by using CBS+/− mice or feeding mice a sulfur amino acid-restricted diet (SARD) led to a marked decrease in differentiated CD4+CD25+Foxp3+ Tregs and an increase in the CD8+ T-cell/Treg ratio. Endogenous or exogenous H2S depletion enhanced the efficacy of anti–PD-L1 and anti–CTLA4 treatment. H2S promoted Treg activation through the persulfidation of ENO1 at cysteine 119. Furthermore, H2S inhibited the migration of CD8+ T cells by increasing the expression of AAK-1 via ELK4 persulfidation at cysteine 25. Overall, reducing H2S levels engenders a favorable immune microenvironment in colorectal cancer by decreasing the persulfidation of ENO1 in Tregs and ELK4 in CD8+ T cells. SARD represents a potential dietary approach to promote responses to immunotherapies in colorectal cancer.
Significance:
H2S depletion increases the CD8+ T-cell/Treg ratio and enhances the efficacy of anti–PD-L1 and anti–CTLA4 treatment in colon cancer, identifying H2S as an anticancer immunotherapy target.
Data from Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer
Authors: Bassiouni Rania , Idowu Michael O. , Gibbs Lee D. , Robila Valentina , Grizzard Pamela J. , Webb Michelle G. , Song Jiarong , Noriega Ashley , Craig David W. , Carpten John D.
Published: March 2023

Abstract
Triple-negative breast cancer (TNBC) is an aggressive disease that disproportionately affects African American (AA) women. Limited targeted therapeutic options exist for patients with TNBC. Here, we employ spatial transcriptomics to interrogate tissue from a racially diverse TNBC cohort to comprehensively annotate the transcriptional states of spatially resolved cellular populations. A total of 38,706 spatial features from a cohort of 28 sections from 14 patients were analyzed. Intratumoral analysis of spatial features from individual sections revealed heterogeneous transcriptional substructures. However, integrated analysis of all samples resulted in nine transcriptionally distinct clusters that mapped across all individual sections. Furthermore, novel use of join count analysis demonstrated nonrandom directional spatial dependencies of the transcriptionally defined shared clusters, supporting a conserved spatio-transcriptional architecture in TNBC. These findings were substantiated in an independent validation cohort comprising 17,861 spatial features representing 15 samples from 8 patients. Stratification of samples by race revealed race-associated differences in hypoxic tumor content and regions of immune-rich infiltrate. Overall, this study combined spatial and functional molecular analyses to define the tumor architecture of TNBC, with potential implications in understanding TNBC disparities.
Significance:
Spatial transcriptomics profiling of a diverse cohort of triple-negative breast cancers and innovative informatics approaches reveal a conserved cellular architecture across cancers and identify proportional differences in tumor cell composition by race.
Data from Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer
Authors: Hagel Kimberly R. , Arafeh Rand , Gang Sydney , Arnoff Taylor E. , Larson Rebecca C. , Doench John G. , Mathewson Nathan D. , Wucherpfennig Kai W. , Maus Marcela V. , Hahn William C.
Published: March 2023

Abstract
Chimeric antigen receptor (CAR) T-cell therapy can lead to dramatic clinical responses in B-cell malignancies. However, early clinical trials with CAR T-cell therapy in non–B-cell malignancies have been disappointing to date, suggesting that tumor-intrinsic features contribute to resistance. To investigate tumor-intrinsic modes of resistance, we performed genome scale CRISPR-Cas9 screens in mesothelin (MSLN)-expressing pancreatic cancer cells. Co-culture with MSLN-targeting CAR T cells identified both antigen-dependent and antigen-independent modes of resistance. In particular, loss of the majority of the genes involved in the pathway responsible for GPI-anchor biosynthesis and attachment abrogated the ability of CAR T cells to target pancreatic cancer cells, suggesting that disruption of this pathway may permit MSLN CAR T-cell evasion in the clinic. Antigen-independent mediators of CAR T-cell response included members of the death receptor pathway as well as genes that regulate tumor transcriptional responses, including TFAP4 and INTS12. TFAP4-mediated CAR T resistance depended on the NFκB transcription factor p65, indicating that tumor resistance to CAR T-cell therapy likely involves alterations in tumor-intrinsic states. Overall, this study uncovers multiple antigen-dependent and -independent mechanisms of CAR T-cell evasion by pancreatic cancer, paving the way for overcoming resistance in this disease that is notoriously refractory to immunotherapy.
Significance:
The identification and validation of key determinants of CAR T-cell response in pancreatic cancer provide insights into the landscape of tumor cell intrinsic resistance mechanisms and into approaches to improve therapeutic efficacy.
Data from Stimulated Raman Scattering Microscopy Enables Gleason Scoring of Prostate Core Needle Biopsy by a Convolutional Neural Network
Authors: Ao Jianpeng , Shao Xiaoguang , Liu Zhijie , Liu Qiang , Xia Jun , Shi Yongheng , Qi Lin , Pan Jiahua , Ji Minbiao
Published: March 2023

Abstract
Focal therapy (FT) has been proposed as an approach to eradicate clinically significant prostate cancer while preserving the normal surrounding tissues to minimize treatment-related toxicity. Rapid histology of core needle biopsies is essential to ensure the precise FT for localized lesions and to determine tumor grades. However, it is difficult to achieve both high accuracy and speed with currently available histopathology methods. Here, we demonstrated that stimulated Raman scattering (SRS) microscopy could reveal the largely heterogeneous histologic features of fresh prostatic biopsy tissues in a label-free and near real-time manner. A diagnostic convolutional neural network (CNN) built based on images from 61 patients could classify Gleason patterns of prostate cancer with an accuracy of 85.7%. An additional 22 independent cases introduced as external test dataset validated the CNN performance with 84.4% accuracy. Gleason scores of core needle biopsies from 21 cases were calculated using the deep learning SRS system and showed a 71% diagnostic consistency with grading from three pathologists. This study demonstrates the potential of a deep learning–assisted SRS platform in evaluating the tumor grade of prostate cancer, which could help simplify the diagnostic workflow and provide timely histopathology compatible with FT treatment.
Significance:
A platform combining stimulated Raman scattering microscopy and a convolutional neural network provides rapid histopathology and automated Gleason scoring on fresh prostate core needle biopsies without complex tissue processing.
Data from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
Authors: Gambi Giovanni , Mengus Gabrielle , Davidson Guillaume , Demesmaeker Ewout , Cuomo Alessandro , Bonaldi Tiziana , Katopodi Vicky , Malouf Gabriel G. , Leucci Eleonora , Davidson Irwin
Published: March 2023

Abstract
Tumor heterogeneity is a key feature of melanomas that hinders development of effective treatments. Aiming to overcome this, we identified LINC00518 (LENOX; lincRNA-enhancer of oxidative phosphorylation) as a melanoma-specific lncRNA expressed in all known melanoma cell states and essential for melanoma survival in vitro and in vivo. Mechanistically, LENOX promoted association of the RAP2C GTPase with mitochondrial fission regulator DRP1, increasing DRP1 S637 phosphorylation, mitochondrial fusion, and oxidative phosphorylation. LENOX expression was upregulated following treatment with MAPK inhibitors, facilitating a metabolic switch from glycolysis to oxidative phosphorylation and conferring resistance to MAPK inhibition. Consequently, combined silencing of LENOX and RAP2C synergized with MAPK inhibitors to eradicate melanoma cells. Melanomas are thus addicted to the lncRNA LENOX, which acts to optimize mitochondrial function during melanoma development and progression.
Significance:
The lncRNA LENOX is a novel regulator of melanoma metabolism, which can be targeted in conjunction with MAPK inhibitors to eradicate melanoma cells.
Supplementary Material from Blood Vitamin D Levels in Relation to Genetic Estimation of African Ancestry
Authors: Signorello Lisa B. , Williams Scott M. , Zheng Wei , Smith Jeffrey R. , Long Jirong , Cai Qiuyin , Hargreaves Margaret K. , Hollis Bruce W. , Blot William J.
Published: March 2023

Supplementary Material from Blood Vitamin D Levels in Relation to Genetic Estimation of African Ancestry
Supplementary Tables 1-3 from Prevalence and Correlates of Smoking and Cessation-Related Behavior among Survivors of Ten Cancers: Findings from a Nationwide Survey Nine Years after Diagnosis
Authors: Westmaas J. Lee , Alcaraz Kassandra I. , Berg Carla J. , Stein Kevin D.
Published: March 2023

Supplementary Table 1. Relationships of sociodemographic, cancer- and other health-related variables with having quit smoking after diagnosis versus current smoking. Supplementary Table 2. Prevalence of intentions to quit in relationship to sociodemographic, cancer, and other health-related variables among current smokers. Supplementary Table 3. Intentions of quitting within a month versus later in relationship to sociodemographic, cancer, and other health-related variables among current smokers.
Supplementary Table 1 from Low to Moderate Alcohol Intake Is Not Associated with Increased Mortality after Breast Cancer
Authors: Flatt Shirley W. , Thomson Cynthia A. , Gold Ellen B. , Natarajan Loki , Rock Cheryl L. , Al-Delaimy Wael K. , Patterson Ruth E. , Saquib Nazmus , Caan Bette J. , Pierce John P.
Published: March 2023

Supplementary Table 1 from Low to Moderate Alcohol Intake Is Not Associated with Increased Mortality after Breast Cancer
Supplementary Table 1 from Accuracy of Perceived Risk of Recurrence Among Patients With Early-Stage Breast Cancer
Authors: Liu Ying , Pérez Maria , Aft Rebecca L. , Massman Kerry , Robinson Erica , Myles Stephanie , Schootman Mario , Gillanders William E. , Jeffe Donna B.
Published: March 2023

Supplementary Table 1 from Accuracy of Perceived Risk of Recurrence Among Patients With Early-Stage Breast Cancer
Supplementary Figure 1 from State Disparities in Colorectal Cancer Mortality Patterns in the United States
Authors: Naishadham Deepa , Lansdorp-Vogelaar Iris , Siegel Rebecca , Cokkinides Vilma , Jemal Ahmedin
Published: March 2023

PDF file - 96K, Percent change in Colorectal Mortality and Incidence Rates, 1992-95 to 2004-07
Supplementary Tables 1-8 from Smoking and Selected DNA Repair Gene Polymorphisms in Controls: Systematic Review and Meta-Analysis
Authors: Hodgson M. Elizabeth , Poole Charles , Olshan Andrew F. , North Kari E. , Zeng Donglin , Millikan Robert C.
Published: March 2023

Supplementary Tables 1-8 from Smoking and Selected DNA Repair Gene Polymorphisms in Controls: Systematic Review and Meta-Analysis
Data Supplement from Are HIV-Infected Men Vulnerable to Prostate Cancer Treatment Disparities?
Authors: Murphy Adam B. , Bhatia Ramona , Martin Iman K. , Klein David A. , Hollowell Courtney M.P. , Nyame Yaw , Dielubanza Elodi , Achenbach Chad , Kittles Rick A.
Published: March 2023

Supplemental Table 2: prostate cancer treatments and codes we used in our study. It distinguishes radical prostatectomy treatments from non-radical prostatectomy treatments.
Supplementary Tables 3A-C from Use of the Predictive Sugars Biomarker to Evaluate Self-Reported Total Sugars Intake in the Observing Protein and Energy Nutrition (OPEN) Study
Authors: Tasevska Nataša , Midthune Douglas , Potischman Nancy , Subar Amy F. , Cross Amanda J. , Bingham Sheila A. , Schatzkin Arthur , Kipnis Victor
Published: March 2023

Supplementary Tables 3A-C from Use of the Predictive Sugars Biomarker to Evaluate Self-Reported Total Sugars Intake in the Observing Protein and Energy Nutrition (OPEN) Study
Supplementary Table 1 from International Trends in Liver Cancer Incidence Rates
Authors: Center Melissa M. , Jemal Ahmedin
Published: March 2023

XLS file - 24K
Supplementary Figure 1 from Improved Stool DNA Integrity Method for Early Colorectal Cancer Diagnosis
Authors: Rengucci Claudia , De Maio Giulia , Menghi Maura , Scarpi Emanuela , Guglielmo Simona , Fusaroli Pietro , Caletti Giancarlo , Saragoni Luca , Gardini Andrea Casadei , Zoli Wainer , Falcini Fabio , Amadori Dino , Calistri Daniele
Published: March 2023

Supplementary Figure 1. Fagan Nomogram analysis. A line is drawn connecting the pre-test probability and the point on the middle vertical line corresponding to the likelihood ratio for the test result, represented by a range of test results (boxes). This line is extended to intersect with the right-hand vertical line, which gives the post-test probability. This point is the new estimate of probability that the patient has the disease. A) Nomogram for post-test probability of having a tumor. B) Nomogram for post-test probability of having a tumor or high-risk adenoma.
Supplementary Table 1 from Nicotine Withdrawal Sensitivity, Linkage to chr6q26, and Association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) Sample
Authors: Hardin Jill , He Yungang , Javitz Harold S. , Wessel Jennifer , Krasnow Ruth E. , Tildesley Elizabeth , Hops Hyman , Swan Gary E. , Bergen Andrew W.
Published: March 2023

Supplementary Table 1 from Nicotine Withdrawal Sensitivity, Linkage to chr6q26, and Association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) Sample
Supplementary Table 1 from International Efforts to Develop Biospecimen Best Practices
Authors: Vaught Jimmie B. , Caboux Elodie , Hainaut Pierre
Published: March 2023

Supplementary Table 1 from International Efforts to Develop Biospecimen Best Practices
Supplementary Table and Figure Legends from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
Authors: Devaney James , Stirzaker Clare , Qu Wenjia , Song Jenny Z. , Statham Aaron L. , Patterson Kate I. , Horvath Lisa G. , Tabor Bruce , Coolen Marcel W. , Hulf Toby , Kench James G. , Henshall Susan M. , Pe Benito Ruth , Haynes Anne-Maree , Mayor Regina , Peinado Miguel A. , Sutherland Robert L. , Clark Susan J.
Published: March 2023

Supplementary Table and Figure Legends from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
Supplementary Figure 3 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
Authors: Devaney James , Stirzaker Clare , Qu Wenjia , Song Jenny Z. , Statham Aaron L. , Patterson Kate I. , Horvath Lisa G. , Tabor Bruce , Coolen Marcel W. , Hulf Toby , Kench James G. , Henshall Susan M. , Pe Benito Ruth , Haynes Anne-Maree , Mayor Regina , Peinado Miguel A. , Sutherland Robert L. , Clark Susan J.
Published: March 2023

Supplementary Figure 3 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
Supplementary Figure 1 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
Authors: Devaney James , Stirzaker Clare , Qu Wenjia , Song Jenny Z. , Statham Aaron L. , Patterson Kate I. , Horvath Lisa G. , Tabor Bruce , Coolen Marcel W. , Hulf Toby , Kench James G. , Henshall Susan M. , Pe Benito Ruth , Haynes Anne-Maree , Mayor Regina , Peinado Miguel A. , Sutherland Robert L. , Clark Susan J.
Published: March 2023

Supplementary Figure 1 from Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers
Supplementary Table 1 from Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer
Authors: Pio Ruben , Garcia Javier , Corrales Leticia , Ajona Daniel , Fleischhacker Michael , Pajares Maria J. , Cardenal Felipe , Seijo Luis , Zulueta Javier J. , Nadal Ernest , Witt Christian , Lozano Maria D. , Schmidt Bernd , Montuenga Luis M.
Published: March 2023

Supplementary Table 1 from Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer
Supplementary Methods from Genetic Polymorphisms in 15q25 and 19q13 Loci, Cotinine Levels, and Risk of Lung Cancer in EPIC
Authors: Timofeeva Maria N. , McKay James D. , Davey Smith George , Johansson Mattias , Byrnes Graham B. , Chabrier Amélie , Relton Caroline , Ueland Per Magne , Vollset Stein Emil , Midttun Øivind , Nygård Ottar , Slimani Nadia , Romieu Isabelle , Clavel-Chapelon Françoise , Boutron-Ruault Marie-Christine , Fagherazzi Guy , Kaaks Rudolf , Teucher Birgit , Boeing Heiner , Weikert Cornelia , Bueno-de-Mesquita H. Bas , van Gils Carla , Peeters Petra H.M. , Agudo Antonio , Barricarte Aurelio , Huerta Jose-Maria , Rodríguez Laudina , Sánchez Maria-José , Larrañaga Nerea , Khaw Kay-Tee , Wareham Nick , Allen Naomi E. , Travis Ruth C. , Gallo Valentina , Norat Teresa , Krogh Vittorio , Masala Giovanna , Panico Salvatore , Sacerdote Carlotta , Tumino Rosario , Trichopoulou Antonia , Lagiou Pagona , Trichopoulos Dimitrios , Rasmuson Torgny , Hallmans Göran , Riboli Elio , Vineis Paolo , Brennan Paul
Published: March 2023

PDF file - 82K
Supplementary Methods from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
Authors: Roylance Rebecca , Endesfelder David , Gorman Patricia , Burrell Rebecca A. , Sander Jil , Tomlinson Ian , Hanby Andrew M. , Speirs Valerie , Richardson Andrea L. , Birkbak Nicolai J. , Eklund Aron C. , Downward Julian , Kschischo Maik , Szallasi Zoltan , Swanton Charles
Published: March 2023

PDF file - 165K, Sweave document describing all statistical analysis performed in research.
Supplementary Figure 4 from Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
Authors: Roylance Rebecca , Endesfelder David , Gorman Patricia , Burrell Rebecca A. , Sander Jil , Tomlinson Ian , Hanby Andrew M. , Speirs Valerie , Richardson Andrea L. , Birkbak Nicolai J. , Eklund Aron C. , Downward Julian , Kschischo Maik , Szallasi Zoltan , Swanton Charles
Published: March 2023

PDF 249K
Supplementary Tables 1 through 3 from Increased Lung and Bladder Cancer Incidence in Adults after In Utero and Early-Life Arsenic Exposure
Authors: Steinmaus Craig , Ferreccio Catterina , Acevedo Johanna , Yuan Yan , Liaw Jane , Durán Viviana , Cuevas Susana , García José , Meza Rodrigo , Valdés Rodrigo , Valdés Gustavo , Benítez Hugo , VanderLinde Vania , Villagra Vania , Cantor Kenneth P. , Moore Lee E. , Perez Saida G. , Steinmaus Scott , Smith Allan H.
Published: March 2023

PDF - 115K, Table S1. Comparison of subjects included in this analysis to subjects excluded because they had high exposures both in early life and adulthood. Table S2. Comparison of residences of the Chile case control study controls at the time of ascertainment to the 2002 Chile census. Table S3. Cancer odds ratios in subjects exposed in utero and childhood using different age categories to define early-life exposure.
Supplementary Figure 1, Tables 1 - 3 from Fine-Mapping IGF1 and Prostate Cancer Risk in African Americans: The Multiethnic Cohort Study
Authors: Giorgi Elena E. , Stram Daniel O. , Taverna Darin , Turner Stephen D. , Schumacher Fredrick , Haiman Christopher A. , Lum-Jones Annette , Tirikainen Maarit , Caberto Christian , Duggan David , Henderson Brian E. , Le Marchand Loic , Cheng Iona
Published: March 2023

PDF file - 1238K, Supplemental Figure 1. Locus Zoom Plot for SNP rs148371593 in African Americans. Supplemental Table 1. Study subject characteristics. Supplemental Table 2. Association between 334 IGF1 variants and prostate cancer risk among African American. Supplemental Table 3. FASTA sequences of 8 novel IGF1 variants.
Supplementary Table 1 from Childhood Exposure to Secondhand Smoke and Functional Mannose Binding Lectin Polymorphisms Are Associated with Increased Lung Cancer Risk
Authors: Olivo-Marston Susan E. , Yang Ping , Mechanic Leah E. , Bowman Elise D. , Pine Sharon R. , Loffredo Christopher A. , Alberg Anthony J. , Caporaso Neil , Shields Peter G. , Chanock Stephen , Wu Yanhong , Jiang Ruoxiang , Cunningham Julie , Jen Jin , Harris Curtis C.
Published: March 2023

Supplementary Table 1 from Childhood Exposure to Secondhand Smoke and Functional Mannose Binding Lectin Polymorphisms Are Associated with Increased Lung Cancer Risk
Supplementary Table 1 from Genetic Variants of Toll-Like Receptor 2 and 5, Helicobacter Pylori Infection, and Risk of Gastric Cancer and Its Precursors in a Chinese Population
Authors: Zeng Hong-Mei , Pan Kai-Feng , Zhang Yang , Zhang Lian , Ma Jun-Ling , Zhou Tong , Su Hui-Juan , Li Wen-Qing , Li Ji-You , Gerhard Markus , Classen Meinhard , You Wei-Cheng
Published: March 2023

PDF file - 109KB
Supplementary Table 1 from Patient and Provider Characteristics Associated with Colorectal, Breast, and Cervical Cancer Screening among Asian Americans
Authors: Thompson Caroline A. , Gomez Scarlett Lin , Chan Albert , Chan John K. , McClellan Sean R. , Chung Sukyung , Olson Cliff , Nimbal Vani , Palaniappan Latha P.
Published: March 2023

Supplementary Table 1. Selected patient characteristics by Cancer screening type and detailed Asian ethnicity
Supplementary Figure 1 from Telomere Length and TERT Functional Polymorphisms Are Not Associated with Risk of Squamous Cell Carcinoma of the Head and Neck
Authors: Liu Zhensheng , Ma Hongxia , Wei Sheng , Li Guojun , Sturgis Erich M. , Wei Qingyi
Published: March 2023

PDF file - 132KB, LD map.
Supplementary Table 1 from 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
Authors: Warren Helen , Dudbridge Frank , Fletcher Olivia , Orr Nick , Johnson Nichola , Hopper John L. , Apicella Carmel , Southey Melissa C. , Mahmoodi Maryam , Schmidt Marjanka K. , Broeks Annegien , Cornelissen Sten , Braaf Linda M. , Muir Kenneth R. , Lophatananon Artitaya , Chaiwerawattana Arkom , Wiangnon Surapon , Fasching Peter A. , Beckmann Matthias W. , Ekici Arif B. , Schulz-Wendtland Ruediger , Sawyer Elinor J. , Tomlinson Ian , Kerin Michael , Burwinkel Barbara , Marme Frederik , Schneeweiss Andreas , Sohn Christof , Guénel Pascal , Truong Thérèse , Laurent-Puig Pierre , Mulot Claire , Bojesen Stig E , Nielsen Sune F. , Flyger Henrik , Nordestgaard Børge G , Milne Roger L. , Benítez Javier , Arias-Pérez José-Ignacio , Zamora M. Pilar , Anton-Culver Hoda , Ziogas Argyrios , Bernstein Leslie , Dur Christina Clarke , Brenner Hermann , Müller Heiko , Arndt Volker , Langheinz Anne , Meindl Alfons , Golatta Michael , Bartram Claus R. , Schmutzler Rita K. , Brauch Hiltrud , Justenhoven Christina , Brüning Thomas , Chang-Claude Jenny , Wang-Gohrke Shan , Eilber Ursula , Dörk Thilo , Schürmann Peter , Bremer Michael , Hillemanns Peter , Nevanlinna Heli , Muranen Taru A. , Aittomäki Kristiina , Blomqvist Carl , Bogdanova Natalia , Antonenkova Natalia , Rogov Yuriy , Bermisheva Marina , Prokofyeva Darya , Zinnatullina Guzel , Khusnutdinova Elza , Lindblom Annika , Margolin Sara , Mannermaa Arto , Kosma Veli-Matti , Hartikainen Jaana M. , Kataja Vesa , Chenevix-Trench Georgia , Beesley Jonathan , Chen Xiaoqing , Lambrechts Diether , Smeets Ann , Paridaens Robert , Weltens Caroline , Flesch-Janys Dieter , Buck Katharina , Behrens Sabine , Peterlongo Paolo , Bernard Loris , Manoukian Siranoush , Radice Paolo , Couch Fergus J. , Vachon Celine , Wang Xianshu , Olson Janet , Giles Graham , Baglietto Laura , McLean Cariona A. , Severi Gianluca , John Esther M. , Miron Alexander , Winqvist Robert , Pylkäs Katri , Jukkola-Vuorinen Arja , Grip Mervi , Andrulis Irene L. , Knight Julia A. , Mulligan Anna Marie , Weerasooriya Nayana , Devilee Peter , Tollenaar Robert A.E.M. , Martens John W.M. , Seynaeve Caroline M. , Hooning Maartje J. , Hollestelle Antoinette , Jager Agnes , Tilanus-Linthorst Madeleine M.A. , Hall Per , Czene Kamila , Liu Jianjun , Li Jingmei , Cox Angela , Cross Simon S. , Brock Ian W. , Reed Malcolm W.R. , Pharoah Paul , Blows Fiona M. , Dunning Alison M. , Ghoussaini Maya , Ashworth Alan , Swerdlow Anthony , Jones Michael , Schoemaker Minouk , Easton Douglas F. , Humphreys Manjeet , Wang Qin , Peto Julian , dos-Santos-Silva Isabel
Published: March 2023

PDF file, 107K, Summary characteristics of the participating BCAC case-control studies.
Supplementary Table 1 from Validating Self-Reported Mammography Use in Vulnerable Communities: Findings and Recommendations
Authors: Allgood Kristi L. , Rauscher Garth H. , Whitman Steven , Vasquez-Jones Giselle , Shah Ami M.
Published: March 2023

PDF - 30K, Study characteristics-abstracted versus not abstracted (facility-reported) and not abstracted (No HIPAA authorization).
Supplementary Table 4 from External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter Cohort
Authors: Chen Li-Mei , Chang Myron , Dai Yunfeng , Chai Karl X. , Dyrskjøt Lars , Sanchez-Carbayo Marta , Szarvas Tibor , Zwarthoff Ellen C. , Lokeshwar Vinata , Jeronimo Carmen , Parker Alexander S. , Ross Shanti , Borre Michael , Ørntoft Torben F. , Jaeger Tobias , Beukers Willemien , Lopez Luis E. , Henrique Rui , Young Paul R. , Urquidi Virginia , Goodison Steve , Rosser Charles J.
Published: March 2023

PDF file - 12K, Ascribed functions of 10-biomarker diagnostic panel.
Supplementary Figure 2, Part 1 from Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies
Authors: Bolton Kelly L. , Garcia-Closas Montserrat , Pfeiffer Ruth M. , Duggan Máire A. , Howat William J. , Hewitt Stephen M. , Yang Xiaohong R. , Cornelison Robert , Anzick Sarah L. , Meltzer Paul , Davis Sean , Lenz Petra , Figueroa Jonine D. , Pharoah Paul D.P. , Sherman Mark E.
Published: March 2023

Supplementary Figure 2, Part 1 from Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies
Supplementary Table 2 from External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter Cohort
Authors: Chen Li-Mei , Chang Myron , Dai Yunfeng , Chai Karl X. , Dyrskjøt Lars , Sanchez-Carbayo Marta , Szarvas Tibor , Zwarthoff Ellen C. , Lokeshwar Vinata , Jeronimo Carmen , Parker Alexander S. , Ross Shanti , Borre Michael , Ørntoft Torben F. , Jaeger Tobias , Beukers Willemien , Lopez Luis E. , Henrique Rui , Young Paul R. , Urquidi Virginia , Goodison Steve , Rosser Charles J.
Published: March 2023

XLSX file - 8K, Comparison of biomarker concentration data across 3 independent cohort studies (n = 755).
Supplementary Table 2A from Refining the Prostate Cancer Genetic Association within the JAZF1 Gene on Chromosome 7p15.2
Authors: Prokunina-Olsson Ludmila , Fu Yi-Ping , Tang Wei , Jacobs Kevin B. , Hayes Richard B. , Kraft Peter , Berndt Sonja I. , Wacholder Sholom , Yu Kai , Hutchinson Amy , Spencer Feigelson Heather , Thun Michael J. , Diver W. Ryan , Albanes Demetrius , Virtamo Jarmo , Weinstein Stephanie , Schumacher Fredrick R. , Cancel-Tassin Geraldine , Cussenot Olivier , Valeri Antoine , Andriole Gerald L. , Crawford E. David , Haiman Christopher A. , Henderson Brian E. , Kolonel Laurence , Le Marchand Loic , Siddiq Afshan , Riboli Elio , Travis Ruth , Kaaks Rudolf , Isaacs William B. , Isaacs Sarah D. , Grönberg Henrik , Wiklund Fredrik , Xu Jianfeng , Vatten Lars J. , Hveem Kristian , Kumle Merethe , Tucker Margaret , Hoover Robert N. , Fraumeni Joseph F. , Hunter David J. , Thomas Gilles , Chatterjee Nilanjan , Chanock Stephen J. , Yeager Meredith
Published: March 2023

Supplementary Table 2A from Refining the Prostate Cancer Genetic Association within the JAZF1 Gene on Chromosome 7p15.2
Supplementary Table 1 from Refining the Prostate Cancer Genetic Association within the JAZF1 Gene on Chromosome 7p15.2
Authors: Prokunina-Olsson Ludmila , Fu Yi-Ping , Tang Wei , Jacobs Kevin B. , Hayes Richard B. , Kraft Peter , Berndt Sonja I. , Wacholder Sholom , Yu Kai , Hutchinson Amy , Spencer Feigelson Heather , Thun Michael J. , Diver W. Ryan , Albanes Demetrius , Virtamo Jarmo , Weinstein Stephanie , Schumacher Fredrick R. , Cancel-Tassin Geraldine , Cussenot Olivier , Valeri Antoine , Andriole Gerald L. , Crawford E. David , Haiman Christopher A. , Henderson Brian E. , Kolonel Laurence , Le Marchand Loic , Siddiq Afshan , Riboli Elio , Travis Ruth , Kaaks Rudolf , Isaacs William B. , Isaacs Sarah D. , Grönberg Henrik , Wiklund Fredrik , Xu Jianfeng , Vatten Lars J. , Hveem Kristian , Kumle Merethe , Tucker Margaret , Hoover Robert N. , Fraumeni Joseph F. , Hunter David J. , Thomas Gilles , Chatterjee Nilanjan , Chanock Stephen J. , Yeager Meredith
Published: March 2023

Supplementary Table 1 from Refining the Prostate Cancer Genetic Association within the JAZF1 Gene on Chromosome 7p15.2
Supplementary Table 1 from Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk
Authors: Permuth-Wey Jennifer , Chen Y. Ann , Tsai Ya-Yu , Chen Zhihua , Qu Xiaotao , Lancaster Johnathan M. , Stockwell Heather , Dagne Getachew , Iversen Edwin , Risch Harvey , Barnholtz-Sloan Jill , Cunningham Julie M. , Vierkant Robert A. , Fridley Brooke L. , Sutphen Rebecca , McLaughlin John , Narod Steven A. , Goode Ellen L. , Schildkraut Joellen M. , Fenstermacher David , Phelan Catherine M. , Sellers Thomas A.
Published: March 2023

Supplementary Table 1 from Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk
Supplementary Figure 3 from Intake of Cruciferous Vegetables Modifies Bladder Cancer Survival
Authors: Tang Li , Zirpoli Gary R. , Guru Khurshid , Moysich Kirsten B. , Zhang Yuesheng , Ambrosone Christine B. , McCann Susan E.
Published: March 2023

Supplementary Figure 3 from Intake of Cruciferous Vegetables Modifies Bladder Cancer Survival
Editorial for This Article from Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection Clearance
Authors: Insinga Ralph P. , Perez Gonzalo , Wheeler Cosette M. , Koutsky Laura A. , Garland Suzanne M. , Leodolter Sepp , Joura Elmar A. , Ferris Daron G. , Steben Marc , Hernandez-Avila Mauricio , Brown Darron R. , Elbasha Elamin , Muñoz Nubia , Paavonen Jorma , Haupt Richard M.
Published: March 2023

Editorial for This Article from Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection Clearance
Supplementary Figure 1 from Intake of Cruciferous Vegetables Modifies Bladder Cancer Survival
Authors: Tang Li , Zirpoli Gary R. , Guru Khurshid , Moysich Kirsten B. , Zhang Yuesheng , Ambrosone Christine B. , McCann Susan E.
Published: March 2023

Supplementary Figure 1 from Intake of Cruciferous Vegetables Modifies Bladder Cancer Survival
Supplementary Table 1 from Context-Dependent Effects of Genome-Wide Association Study Genotypes and Macroenvironment on Time to Biochemical (Prostate Specific Antigen) Failure after Prostatectomy
Authors: Rebbeck Timothy R. , Weber Anita L. , Walker Amy H. , Stefflova Klara , Tran Teo V. , Spangler Elaine , Chang Bao-Li , Zeigler-Johnson Charnita M.
Published: March 2023

Supplementary Table 1 from Context-Dependent Effects of Genome-Wide Association Study Genotypes and Macroenvironment on Time to Biochemical (Prostate Specific Antigen) Failure after Prostatectomy
Supplementary Table 3 from Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
Authors: Archer Kellie J. , Mas Valeria R. , David Krystle , Maluf Daniel G. , Bornstein Karen , Fisher Robert A.
Published: March 2023

Supplementary Table 3 from Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
Supplementary Figure 1 from Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
Authors: Archer Kellie J. , Mas Valeria R. , David Krystle , Maluf Daniel G. , Bornstein Karen , Fisher Robert A.
Published: March 2023

Supplementary Figure 1 from Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
Supplementary Figure Legends, Table Legends from Imaging Features of HER2 Overexpression in Breast Cancer: A Systematic Review and Meta-analysis
Authors: Elias Sjoerd G. , Adams Arthur , Wisner Dorota J. , Esserman Laura J. , van't Veer Laura J. , Mali Willem P.Th.M. , Gilhuijs Kenneth G.A. , Hylton Nola M.
Published: March 2023

PDF file - 53KB
Supplementary Table 1 from Genetic Variants in XRCC2: New Insights Into Colorectal Cancer Tumorigenesis
Authors: Curtin Karen , Lin Wei-Yu , George Rina , Katory Mark , Shorto Jennifer , Cannon-Albright Lisa A. , Smith Gillian , Bishop D. Timothy , Cox Angela , Camp Nicola J.
Published: March 2023

Supplementary Table 1 from Genetic Variants in XRCC2: New Insights Into Colorectal Cancer Tumorigenesis
Supplementary Table 1 from DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations
Authors: Gaudet Mia M. , Campan Mihaela , Figueroa Jonine D. , Yang Xiaohong R. , Lissowska Jolanta , Peplonska Beata , Brinton Louise A. , Rimm David L. , Laird Peter W. , Garcia-Closas Montserrat , Sherman Mark E.
Published: March 2023

Supplementary Table 1 from DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations
Supplementary Figure 1 from The Paracrine Hormone for the GUCY2C Tumor Suppressor, Guanylin, Is Universally Lost in Colorectal Cancer
Authors: Wilson Chantell , Lin Jieru E. , Li Peng , Snook Adam E. , Gong Jianping , Sato Takahiro , Liu Chengbao , Girondo Melanie A. , Rui Hallgeir , Hyslop Terry , Waldman Scott A.
Published: March 2023

Supplementary Figure 1 - Time to recurrence in stage I (blue), II (yellow), and III (black) patients with colorectal cancer.
Supplementary Table 2 from Circulating Folate, Vitamin B12, Homocysteine, Vitamin B12 Transport Proteins, and Risk of Prostate Cancer: a Case-Control Study, Systematic Review, and Meta-analysis
Authors: Collin Simon M. , Metcalfe Chris , Refsum Helga , Lewis Sarah J. , Zuccolo Luisa , Smith George Davey , Chen Lina , Harris Ross , Davis Michael , Marsden Gemma , Johnston Carole , Lane J. Athene , Ebbing Marta , Bønaa Kaare Harald , Nygård Ottar , Ueland Per Magne , Grau Maria V. , Baron John A. , Donovan Jenny L. , Neal David E. , Hamdy Freddie C. , Smith A. David , Martin Richard M.
Published: March 2023

Supplementary Table 2 from Circulating Folate, Vitamin B12, Homocysteine, Vitamin B12 Transport Proteins, and Risk of Prostate Cancer: a Case-Control Study, Systematic Review, and Meta-analysis
Supplementary Table 1 from Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 Carriers
Authors: Neuhausen Susan L. , Brummel Sean , Ding Yuan Chun , Steele Linda , Nathanson Katherine L. , Domchek Susan , Rebbeck Timothy R. , Singer Christian F. , Pfeiler Georg , Lynch Henry T. , Garber Judy E. , Couch Fergus , Weitzel Jeffrey N. , Godwin Andrew , Narod Steven A. , Ganz Patricia A. , Daly Mary B. , Isaacs Claudine , Olopade Olufunmilayo I. , Tomlinson Gail E. , Rubinstein Wendy S. , Tung Nadine , Blum Joanne L. , Gillen Daniel L.
Published: March 2023

Supplementary Table 1 from Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 Carriers
Supplementary Table 1 from Genetic Variation in VEGF Family Genes and Breast Cancer Risk: A Report from the Shanghai Breast Cancer Genetics Study
Authors: Beeghly-Fadiel Alicia , Shu Xiao-Ou , Lu Wei , Long Jirong , Cai Qiuyin , Xiang Yong-Bing , Zheng Ying , Zhao Zhongming , Gu Kai , Gao Yu-Tang , Zheng Wei
Published: March 2023

Supplementary Table 1 from Genetic Variation in VEGF Family Genes and Breast Cancer Risk: A Report from the Shanghai Breast Cancer Genetics Study
Supplementary Materials and Methods from The Role of Genome Sequencing in Personalized Breast Cancer Prevention
Authors: Sieh Weiva , Rothstein Joseph H. , McGuire Valerie , Whittemore Alice S.
Published: March 2023

This Supplement contains additional information on the following topics: development of the full and partial breast cancer risk scores and their variance in the US population, evaluating the performance of strategies that classify young women into high and low risk groups on the basis of their risk scores, and the genetic susceptibility variants used to develop the partial risk scores.
Supplementary Figure S2 from Circulating Mitochondrial DNA Level, a Noninvasive Biomarker for the Early Detection of Gastric Cancer
Authors: Fernandes Julien , Michel Valérie , Camorlinga-Ponce Margarita , Gomez Alejandro , Maldonado Carmen , De Reuse Hilde , Torres Javier , Touati Eliette
Published: March 2023

Supplementary Figure S2 : Analyses of the influence of age on peripheral leukocytes mtDNA content and on serological level of IL-8 in peripheral blood in cohorts 1 and 2. A) In cohort 1 Pearson correlation did not show any significant effect of age on mtDNA content when considering healthy, NAG and GC groups independently; however the analysis on the whole cohort showed a weak influence (p-value=0.04). Importantly, when considering together healthy plus NAG patients (shown as insert in the graph cohort 1) no significant correlation was observed, despite the presence of several older individuals within these patients. These data suggest that the correlation observed in the whole cohort was due to the significantly higher levels of mtDNA found in GC patients compared to healthy and NAG groups. B) No influence of age was observed on IL-8 levels when considering neither each disease group independently nor the whole cohort 1. C) In cohort 2, as in cohort 1, the Pearson correlation analysis did not show any significant correlation with age and mtDNA content when considering NAG, IM or GC groups independently. However, in the whole cohort a weak influence of age on mtDNA was observed (p-value=0.04). As for cohort 1, when the analysis included only NAG plus IM patients (shown as insert in the graph cohort 2), no significant correlation was observed despite the advanced age of some patients in these groups, specially among IM patients for which mean age was similar to GC patients.
Supplementary Table S3 from Shorter Leukocyte Telomere Length Is Independently Associated with Poor Survival in Patients with Bladder Cancer
Authors: Russo Alessia , Modica Federica , Guarrera Simonetta , Fiorito Giovanni , Pardini Barbara , Viberti Clara , Allione Alessandra , Critelli Rossana , Bosio Andrea , Casetta Giovanni , Cucchiarale Giuseppina , Destefanis Paolo , Gontero Paolo , Rolle Luigi , Zitella Andrea , Fontana Dario , Frea Bruno , Vineis Paolo , Sacerdote Carlotta , Matullo Giuseppe
Published: March 2023

Supplementary Table S3. Multivariate Cox regression survival analysis, including TL, age, TG, BCG, radical cystectomy, radiotherapy and chemotherapy. All cause of death.
Supplementary Table 1 from Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma
Authors: Boyd Kevin D. , Ross Fiona M. , Chiecchio Laura , Dagrada GianPaolo , Konn Zoe J. , Tapper William J. , Walker Brian A. , Wardell Christopher P. , Gregory Walter M. , Szubert Alex J. , Davies Faith E. , Morgan Gareth J.
Published: March 2023

Supplementary Table 1 from Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma
Supplementary Table 1 from Circulation of Progenitor Cells in Obese and Lean Colorectal Cancer Patients
Authors: Bellows Charles F. , Zhang Yan , Chen Jinyun , Frazier Marsha L. , Kolonin Mikhail G.
Published: March 2023

PDF file - 53K
Supplementary Figure 2 from Circulation of Progenitor Cells in Obese and Lean Colorectal Cancer Patients
Authors: Bellows Charles F. , Zhang Yan , Chen Jinyun , Frazier Marsha L. , Kolonin Mikhail G.
Published: March 2023

PDF file - 102K
Supplementary Tables 1 through 5 from Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands
Authors: Vos Janet R. , Teixeira Natalia , van der Kolk Dorina M. , Mourits Marian J.E. , Rookus Matti A. , van Leeuwen Flora E. , Collée Margriet , van Asperen Christi J. , Mensenkamp Arjen R. , Ausems Margreet G.E.M. , van Os Theo A.M. , Meijers-Heijboer Hanne E.J. , Gómez-Garcia Encarna B. , Vasen Hans F. , Brohet Richard M. , van der Hout Annemarie H. , Jansen Liesbeth , Oosterwijk Jan C. , de Bock Geertruida H.
Published: March 2023

Supplementary Table 1. Clinical characteristics of BRCA1/2 carriers including index cases in the Northern Netherlands (study population) and in the rest of the Netherlands (reference population). Supplementary Table 2. Overview of number of carriers (excluding index cases) at risk at each age-decade and number of breast cancer event for each age-decade. Supplementary Table 3. Cumulative incidence of breast cancer in BRCA1/2 carriers, excluding index cases, in the study population (Northern Netherlands) and reference population (rest of the Netherlands). Estimation of risks weighted to an equal contribution from the different birth cohorts in each population. Supplementary Table 4. Relative risks (hazard ratios (95% confidence interval)) of breast cancer for mutation spectrum, excluding index cases. Supplementary Table 5. Regional differences in the breast cancer risk of BRCA1/2 carriers including index cases (adjusted for birth year) in the Netherlands: the study population (Northern Netherlands) compared to the reference population (the rest of the Netherlands.)
Supplementary Figure Legends from Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Authors: Ge Lisheng , Baskic Dejan , Basse Per , Vujanovic Lazar , Unlu Sebnem , Yoneyama Toshie , Vujanovic Andrea , Han Jie , Bankovic Dragic , Szczepanski Miroslaw J. , Hunt Jennifer L. , Herberman Ronald B. , Gollin Susanne M. , Ferris Robert L. , Whiteside Theresa L. , Myers Eugene N. , Vujanovic Nikola L.
Published: March 2023

Supplementary Figure Legends from Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Supplementary Table 3 from Manganese Superoxide Dismutase Polymorphism and Risk of Gastric Lesions, and Its Effects on Chemoprevention in a Chinese Population
Authors: Tu Hua-kang , Pan Kai-feng , Zhang Yang , Li Wen-qing , Zhang Lian , Ma Jun-ling , Li Ji-you , You Wei-cheng
Published: March 2023

Supplementary Table 3 from Manganese Superoxide Dismutase Polymorphism and Risk of Gastric Lesions, and Its Effects on Chemoprevention in a Chinese Population
Supplementary Figure 1 from Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Authors: Ge Lisheng , Baskic Dejan , Basse Per , Vujanovic Lazar , Unlu Sebnem , Yoneyama Toshie , Vujanovic Andrea , Han Jie , Bankovic Dragic , Szczepanski Miroslaw J. , Hunt Jennifer L. , Herberman Ronald B. , Gollin Susanne M. , Ferris Robert L. , Whiteside Theresa L. , Myers Eugene N. , Vujanovic Nikola L.
Published: March 2023

Supplementary Figure 1 from Sheddase Activity of Tumor Necrosis Factor-α Converting Enzyme Is Increased and Prognostically Valuable in Head and Neck Cancer
Supplementary Table 1 from Manganese Superoxide Dismutase Polymorphism and Risk of Gastric Lesions, and Its Effects on Chemoprevention in a Chinese Population
Authors: Tu Hua-kang , Pan Kai-feng , Zhang Yang , Li Wen-qing , Zhang Lian , Ma Jun-ling , Li Ji-you , You Wei-cheng
Published: March 2023

Supplementary Table 1 from Manganese Superoxide Dismutase Polymorphism and Risk of Gastric Lesions, and Its Effects on Chemoprevention in a Chinese Population
Supplementary Table 2 from Comparison of Two Methods for Estimating Absolute Risk of Prostate Cancer Based on Single Nucleotide Polymorphisms and Family History
Authors: Hsu Fang-Chi , Sun Jielin , Zhu Yi , Kim Seong-Tae , Jin Tao , Zhang Zheng , Wiklund Fredrik , Kader A. Karim , Zheng S. Lilly , Isaacs William , Grönberg Henrik , Xu Jianfeng
Published: March 2023

Supplementary Table 2 from Comparison of Two Methods for Estimating Absolute Risk of Prostate Cancer Based on Single Nucleotide Polymorphisms and Family History
Supplementary Figure 1 from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
Authors: Beiki Omid , Granath Fredrik , Allebeck Peter , Akre Olof , Moradi Tahereh
Published: March 2023

Supplementary Figure 1 from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
Data Supplement from Biomarkers for Early Detection of Colorectal Cancer and Polyps: Systematic Review
Authors: Shah Reena , Jones Emma , Vidart Victoire , Kuppen Peter J.K. , Conti John A. , Francis Nader K.
Published: March 2023

Supplementary Table 1. Calculations of Positive and Negative Predictive Values of gFOBT within the Context of CRC Disease Prevalence
Supplementary Appendix B from Association of Insurance and Race/Ethnicity with Disease Severity among Men Diagnosed with Prostate Cancer, National Cancer Database 2004-2006
Authors: Fedewa Stacey A. , Etzioni Ruth , Flanders W. Dana , Jemal Ahmedin , Ward Elizabeth M.
Published: March 2023

Supplementary Appendix B from Association of Insurance and Race/Ethnicity with Disease Severity among Men Diagnosed with Prostate Cancer, National Cancer Database 2004-2006
Supplementary Figure Legend from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
Authors: Bianco-Miotto Tina , Chiam Karen , Buchanan Grant , Jindal Shalini , Day Tanya K. , Thomas Mervyn , Pickering Marie A. , O'Loughlin Melissa A. , Ryan Natalie K. , Raymond Wendy A. , Horvath Lisa G. , Kench James G. , Stricker Phillip D. , Marshall Villis R. , Sutherland Robert L. , Henshall Susan M. , Gerald William L. , Scher Howard I. , Risbridger Gail P. , Clements Judith A. , Butler Lisa M. , Tilley Wayne D. , Horsfall David J. , Ricciardelli Carmela
Published: March 2023

Supplementary Figure Legend from Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development